BackAcasti Pharma Overview

Acasti Pharma Net Income

Profitability analysis for ACST.

Quarterly Net Income

-$2.31M
51.37% YoY

As of Dec 2025

Annual Net Income (TTM)

-$8.57M
41.68% YoY

Trailing 12 months ending Dec 2025

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...